The aims of this study were to assess the protective effect of inhibition or knockdown of Smyd2 on cisplatin‐induced kidney injury in CKD mice through pharmacological inhibition of AZ505 and conditional knockdown of Smyd2 in mouse renal tubular epithelial cells. This evidence concerns the gene SMYD2 and chronic kidney disease.